Patents by Inventor Sandra HUYSSEUNE

Sandra HUYSSEUNE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUNDS AS SELF-TANNING SUBSTANCES AND TANNING COMPOSITIONS THEREOF
    Publication number: 20240058240
    Abstract: A self-tanning composition, such as a sunless tanning composition, a moisturizing composition, or a haircare composition, includes a self-tanning substance. The composition can result in increasing the amount of melanin in melanocytes, increasing melanin synthesis, improving melanin transport, and/or improving the distribution of melanin in suprabasal layers. The composition can be used in methods for darkening skin and/or for sunless tanning.
    Type: Application
    Filed: June 25, 2021
    Publication date: February 22, 2024
    Inventors: Sandra HUYSSEUNE, Alex VEITHEN, Yannick QUESNEL
  • Olfactory receptor involved in the perception of musk fragrance and the use thereof
    Patent number: 11867685
    Abstract: The invention relates to the identification of OR5A2 as an Olfactory Receptor that binds natural musk and synthetic musks. The invention encompasses the use of the interaction of OR5A2 polypeptides and nitromusk, polycyclic musk, macrocyclic musk and alicyclic musks as the basis of screening assays for agents that specifically modulate the activity of the OR of the invention.
    Type: Grant
    Filed: December 5, 2018
    Date of Patent: January 9, 2024
    Assignee: CHEMCOM S.A.
    Inventors: Sandra Huysseune, Alex Veithen, Yannick Quesnel
  • OLFACTORY RECEPTOR INVOLVED IN THE PERCEPTION OF MUSK FRAGRANCE AND THE USE THEREOF
    Publication number: 20210164967
    Abstract: The invention relates to the identification of OR5A2 as an Olfactory Receptor that binds natural musk and synthetic musks. The invention encompasses the use of the interaction of OR5A2 polypeptides and nitromusk, polycyclic musk, macrocyclic musk and alicyclic musks as the basis of screening assays for agents that specifically modulate the activity of the OR of the invention.
    Type: Application
    Filed: December 5, 2018
    Publication date: June 3, 2021
    Inventors: Sandra HUYSSEUNE, Alex VEITHEN, Yannick QUESNEL